To evaluate whether a complete loss of p53 would lead to greater effects, we compared the effects of PRMT5 inhibition on growth of the colon cancer cell line, SW48, and a genetic p53 knockout cell line, SW48 p53−/− (Fig. 5D). The gene discussed is TP53; the disease is colonic neoplasm.